Securities Code: 001323 Securities Abbreviation: Musleep Co., Ltd. Announcement No.: 2026-012
Musleep Health Sleep Co., Ltd.
Announcement on the 2026 Salary (Allowance) Plan for Directors and Senior Management
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from false records, misleading statements, or major omissions.
To further standardize the performance evaluation and compensation management of the Company's directors and senior management, motivate directors and senior management to perform their duties diligently, and promote the company's profit growth and sustainable development, in accordance with the "Company Law of the People's Republic of China," the "Securities Law of the People's Republic of China," the "Corporate Governance Guidelines for Listed Companies," and the "Articles of Association," and taking into comprehensive consideration the Company's actual situation, industry and regional compensation levels, and job contributions, upon the proposal of the Board's Compensation and Appraisal Committee, and in conjunction with the compensation levels of directors and senior management in 2025, the 2026 compensation plan for directors and senior management has been specially formulated.
The Company held the eighteenth meeting of the second Board of Directors on April 27, 2026, and deliberated on the "Proposal on the 2026 Salary (Allowance) Plan for Directors and Senior Management." As this proposal involves the compensation of all directors, all directors abstained from voting. The proposal was directly submitted to the Company's 2025 Annual Shareholders' Meeting for deliberation. The 2026 Salary (Allowance) Plan for Directors and Senior Management requires approval by the Shareholders' Meeting to take effect. The specific plan is as follows: